Critical vasospasm during fingolimod (FTY720) treatment in a patient with multiple sclerosis.
Schwarz
A
A
Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.
Korporal
M
M
Hosch
W
W
Max
R
R
Wildemann
B
B
D000328:Adult; D001132:Arm / Q000098:blood supply*; D001783:Blood Flow Velocity / Q000187:drug effects / Q000502:physiology; D005260:Female; D000068876:Fingolimod Hydrochloride; D006801:Humans; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D011409:Propylene Glycols / Q000009:adverse effects*; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives*; D014652:Vascular Diseases / Q000139:chemically induced* / Q000175:diagnosis* / Q000503:physiopathology
D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine